1. Tremaine WJ, Sandborn WJ. Practice guidelines for inflammatory bowel disease: an instrument for assessment. Mayo Clin Proc 1999; 74: 495–501.
2. Miner PB Jr, Peppercorn MA, Targan SR. A rational approach to 5-aminosalicylic acid therapy in ulcerative colitis. Hosp Pract (Off Ed) 1993; 28(Suppl.)3: 1–24.
3. Loftus EV Jr, Sandborn WJ. Drug therapy for inflammatory bowel disease. Contemp Intern Med 1995; 7: 21–34.
4. Williams CN, Haber G, Aquino JA. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTclabeled 5-ASA suppositories. Dig Dis Sci 1987; 32: 71–5S.
5. Jay M, Beihn RM, Digenis GA, Deland FH, Caldwell L, Mlodozeniec AR. Disposition of radiolabelled suppositories in humans. J Pharm Pharmacol 1985; 37: 266–8.